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flow, was mildly increased at 1 hr (2.0+2.3), then increased over the first week peaking at 
day 4 (5.6+2.6), then declined rapidly (0.950.7 at day 26). The MB, Signal peak pre- 
ceded increases in normalized blood flow and blood volume, were not detected until after 
day 14 (0.52+0.11 and 0.87*0.09, for blood flow and volume at 28 days). MB, Signal 
peak also preceded an increase in ischemic muscle tissue PO, (normalized values Of 
0.24+0.06 and 0.47+0.10, at 1 hr and 28 days, respectively). 
We conclude that CEU with microbubbles targeted for endothelial a,-in&grins can be 
used to non-invasively assess anglogenic responses in skeletal muscle. These results 
suggest that targeted CEU imaging of endothelial markers of angiogenesis may poten- 
tially be used for assessing intrinsic and therapeutic angiogenesis prior to changes tn 
perfusion. 
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BACKGROUND: Although perlluorocarbon containing albumin microbubbles (PESDA) 
can bind large quantities of antlsense (AS) to the c-myc protooncogene (anti-c-myc) 
which promotes intimal hyperpasia. it is unknown how much c-myc synthesis within the 
intracoronary (IC) stent or balloon injury is actually suppressed by this intravenous (IV) 
targeting technique in the early period following vascular injury. To examine this, we par- 
formed high phase liquid chromatography of AS to c-myc uptake and Western Blot stud- 
ies of c-myc protein synthesis in coronary arteries from eight pigs 90 minutes following IC 
stent and balloon injury (two vessels per pig). Pigs were treated with either direct IC anti- 
c-myc (4 milligrams), or the same dose of anti-c-myc IV bound or unbound to PESDA. IV 
PESDA containing anti-c-myc was given in the presence or absence of transthoracic 1 
megahertz ultrasound (TTU) (pulsed wave at 0.6 W/cm?. RESULTS: C-myc protein syn- 
thesis in the injured coronary arteries (normalized for control vessels) was significantly 
lower when pigs were given IV anti-c-myc bound to PESDA irrespective of whether TTU 
was concomitantly delivered (TABLE). Suppression of c-myc synthesis was comparable 
to direct IC injection. CONCLUSION: These data confirm that simply binding anti-c-myc 
to IV PESDA is a non-invasive method of targeting therapeutic genes to selective sites of 
IC balloon or stent injury and suppressing the formation of the c-myc protooncogene 
which mediates intimal hyperplasia and restenosis. 
*p<O.O5 compared to other groups (ANOVA) 
Background: Identification of tumor angiogenesis could potentially be used for early 
diagnosis of neoplasms and for prognosis. We hypothesized that contrast-enhanced 
ultrasound (CEU) with microbubbles targeted to endothelial qp3 expressed in neoves- 
sels could be used to assess tumor angiogenesis. 
Methods: We created a brain tumor model where I@ U87MG cells derived from a 
human glioblastoma tumor cell line were embedded in gelfoam and injected intracere- 
brally in athymic rats. Tumors were assessed after either 14 or 28 days of growth (n=4 for 
each). Control rats (n=4) were injected with gelfoam alone. Targeted CEU imaging was 
performed 15 min following i.v. injection of control microbubbles (MB) or qpa targeted 
microbubbles (MB,) bearing the disintegrin echistatin on their surface. Cerebral perfu- 
sion was assessed by CEU during continuous infusion of non-targeted microbubbles. A 
corresponding brain slice was processed for immunohistochemistry 
Results: Tumors were -4-fold larger at day 28 compared to day 14 (p.zO.05). Perfusion 
was detected within all tumors and was characterized by low microvascular blood veloc- 
ity. On histology, 15-50 pm neovessels were abundant within the tumor and stained pos- 
itive for endothelial PECAM-1. Dense staining for a& on the endothelium was found 
within tumors, especially at the outer margins. whereas minimal staining was seen in 
control regions. On CEU. M& signal intensity in gelfoam injection sites was low and sim- 
ilar to that in the contralateral hemisphere. At both 14 and 28 days, MB, signal in tumors 
was significantly (p<O.Ol) greater than that for MQ in normal control regions, or for MB 
within the tumor. MBE signal in tumors was greater at 28 versus 14 days (~~0.05). and 
was greatest at the peripheral margins of the tumors. M& intensity within tumors corra- 
lated well with microvascular blood volume derived from CEU perfusion imaging (w0.83, 
P<O.Ol). 
Conclusions: CEU with microbubbles targeted for endothelial a_& can be used to 
assess tumor angiogenesis. These results have impoltant implications for developing 
methods for early detection of primary or metastatic disease, or for developing novel anti- 
neoplastic therapies with microbubble delivery systems. 
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Direct IC AS IV AS/PESDA IV AS/PESDA IV AS +TTU 
+ TTU 
c-myc protein 0.94+0.26 0.88+0.11 0.8920.28 2.1 lr0.28 
ratio 
anh-c-myc 13+16 24+3 312.6 29i38 
Uptake (nanograms) 
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BACKGROUND: Intravenous (IV) perfluorocarbon containing microbubbles (PCMB) and 
transthoracic ultrasound (TrU) could potentially be used to improve epicardial recanali- 
zation rates (ERR) following acute coronary thrombotic occlusion. One limitation with this 
method is that inadequate PCMB reach the occluded coronary thrombus (CT) following 
IV injection. We hypothesized that attaching a ligand to the PCMB which binds to acti- 
vated platelets within the CT would increase microbubble concentration at the site of the 
CT and enhance cavitation-induced lysis. Accordingly, we compared ERR following 
acute left circumflex thrombotic occlusion I” 50 pigs who were randomized to receive 
either IV tissue plasmlnogen activator (TPA) alone, versus IV TPA in combination with 
TTU and unlabelled IV PCMB (PESDA); or TrlJ with IV PCMB containing 50 u/kg of Epti- 
fabitide (E-P&DA). TTU was intermittent 1 Megahertz at 1.5 Watt&+. Recanalization 
was assessed angiographically at 60 minutes following treatment. RESULTS: Activated 
clotting times were not different following any of the treatments. However, the Figure 
demonstrates that ERR mcreased from ~20% with TPA alone to 60% with IV TPA and IV 
E-PESDA combined with TTU. CONCLUSION: These data indicate that IV E-PESDA 
can be used to increase delivery of microbubbles to acute coronary thrombotic occlu- 
sions and improve ultrasound-directed recanalization of the infarct related artery. 
We have previously shown that ultrasound targeted microbubble destruction (UTMD) can 
augment expression of an adenoviral reporter in the heart. We now show that this 
method can selectively deliver transgenes to two organs that are particularly inaccessible 
to non-invasive strategies (pancreas and brain) and can be extended to plasmid vectors. 
Recombinant adenoviruses or plasmids containing expression constructs of beta-galac- 
tosidase and luciferase wars incorporated into albumin-coated perfluoropropane-filled 
microbubbles during their preparation. These bubbles were infused into the internal jugu- 
lar vein of rats and destroyed with ultrasound while passing through the target organ. 
Organs were harvested after 4 days and analyzed for reporter gene activity. Luciferase 
activity in organs targeted with adenovirus was 104 times higher than in control organs. 
However, liver activity was even higher. Histological examination revealed transgene- 
derived beta-galactosidase activity in subsets of brain neurons and pancreatic islets. 
Luciferase transfection with plasmids showed highly specific gene expression in the 
heart, lo-fold lower than obtained with adenovirus, but with negligible activity in liver (fig- 
ure). We conclude that ultrasound targeted microbubble destruction can markedly 
Improve the range and specificity of gene delivery. This technique heralds a new class of 
strategies for non-invasive gene therapy 
